Takeda Oncology Co-Pay Assistance Progam
Takeda Oncology
OpenVerified·Apr 25, 2026
The Takeda Oncology Co-Pay Assistance Program assists commercially insured patients with reducing out-of-pocket co-pay costs for ALUNBRIG (brigatinib) medication. This program does not appear to offer any travel assistance or cover travel-related expenses.
- Covers
- financial assistance
- Enrollment cycle
- rolling
Apply
Application goes directly to Takeda Oncology. RxCopays does not receive compensation.
Go to application →Status source
the Takeda Oncology Co-Pay Assistance Program may be able to help reduce the out-of-pocket costs associated with ALUNBRIG.
Rare-disease support beyond financial help
This grant covers 7 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: